Prenatal Screening (Nongenetic)
Customize your policy alerts
Sign up for Blue Cross Blue Shield - Illinois Policy RPLAB014 alerts
Get alerted when Policy RPLAB014 changes without checking for updates manually.
Monitor payer policy activity
This policy governs reimbursement criteria and coding for selected nongenetic prenatal screening services for pregnant individuals, including potentially reimbursable routine screening, fetal fibronectin testing, and nonreimbursable services, subject to applicable Plan documents and product requirements.
Prenatal screening guidance was reorganized so recommendations for bacteriuria, diabetes, hepatitis, HIV, thyroid disease, tuberculosis, and Zika virus are addressed in corresponding policies.
Multiple prior prenatal screening subcriteria and associated procedure codes were removed from this policy.
The exclusion for salivary hormone testing was clarified to state that testing salivary hormone levels to assess risk of preterm labor is not reimbursable.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.